Patents by Inventor Faye Seyedi

Faye Seyedi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8470804
    Abstract: 11a,12-dehydrotetracycline compounds are described.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: June 25, 2013
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Joel Berniac, Mohamed Y. Ismail, Mark L. Nelson, Faye Seyedi
  • Publication number: 20120101070
    Abstract: 11a,12-dehydrotetracycline compounds are described.
    Type: Application
    Filed: December 29, 2011
    Publication date: April 26, 2012
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: Joel Berniac, Mohamed Y. Ismail, Mark L. Nelson, Faye Seyedi
  • Patent number: 8088755
    Abstract: 11a,12-dehydrotetracycline compounds are described.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: January 3, 2012
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Joel Berniac, Mohamed Y. Ismail, Mark L. Nelson, Faye Seyedi
  • Publication number: 20060281717
    Abstract: 11a, 12-dehydrotetracycline compounds are described.
    Type: Application
    Filed: February 6, 2006
    Publication date: December 14, 2006
    Inventors: Joel Berniac, Mohamed Ismail, Mark Nelson, Faye Seyedi
  • Patent number: 6743937
    Abstract: Methods of synthesizing a phosphate ester of combretastatin A-4 and trans-isomers thereof in which combretastatin A-4 is reacted with dibenzylphosphite in the presence of carbon tetrabromide, or with 2,2,2-trichloroethyl phosphorodichloridate, to form a phosphate ester of combretastatin A-4 with protecting groups thereon.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: June 1, 2004
    Assignee: OxiGene, Inc.
    Inventors: Faye Seyedi, Jonathan Gale, Reem Haider, John Hoare, Amy Baldwin
  • Publication number: 20020119951
    Abstract: Methods of synthesizing a phosphate ester of combretastat-in A-4 and trans-isomers thereof in which combretastatin A-4 is reacted with dibenzylphosphite in the presence of carbon tetrabromide, or with 2,2,2-trichloroethyl phosphorodichloridate, to form a phosphate ester of combretastatin A-4 with protecting groups thereon.
    Type: Application
    Filed: July 17, 2001
    Publication date: August 29, 2002
    Inventors: Faye Seyedi, Jonathan Gale, Reem Haider, John Hoare, Amy Baldwin